Gene fusions involving the cytokine receptors CRLF2 and EPOR with IGH/IGK occur in approximately 6–14% of B-ALL diagnoses for older children, adolescents and adults and are associated with high-risk disease [22]. This evidence concerns the gene CRLF2 and precursor B-cell acute lymphoblastic leukemia.